ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of Stockholders
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) announced log-in details for its 2021 Virtual Annual Meeting of Stockholders on June 2, 2021, at 10 a.m. Eastern Time. Stockholders of record as of April 26, 2021, can vote and submit questions during the meeting via a provided control number. Participants can log in starting at 9:45 a.m. An annual meeting replay will be available for one year. ANI is a specialty pharmaceutical company focusing on the development and manufacturing of branded and generic prescription pharmaceuticals, including narcotics and oncolytics.
- Stockholders can participate in the virtual annual meeting, promoting shareholder engagement.
- Replay of the meeting available for one year, enhancing transparency.
- None.
ANI Pharmaceuticals, Inc. (“ANI“ or the “Company“) (Nasdaq: ANIP) today announced log-in details for its 2021 Virtual Annual Meeting of Stockholders to be held on June 2, 2021, beginning at 10 a.m. Eastern Time.
Stockholders can attend the virtual annual meeting via the internet at www.virtualshareholdermeeting.com/ANIP2021. Stockholders of record as of the close of business on April 26, 2021 will be eligible to vote their shares and submit questions electronically in advance of and during the virtual annual meeting by using the 16-digit control number included on their individual proxy card or on the voting instruction form accompanying the proxy materials to attend the annual meeting. Stockholders may begin to log in to the meeting platform beginning at 9:45 a.m. Eastern Time on June 2, 2021. We recommend that stockholders log in at that time to ensure they are logged in when the meeting starts.
A replay of the meeting will be available for one year following the meeting date. To listen to a replay of the annual meeting, please visit www.virtualshareholdermeeting.com/ANIP2021.
About ANI
ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The Company’s targeted areas of product development currently include narcotics, oncolytics (anti-cancers), hormones and steroids, and complex formulations involving extended release and combination products. For more information, please visit our website www.anipharmaceuticals.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210601006001/en/
FAQ
When is the ANI Pharmaceuticals Virtual Annual Meeting of Stockholders?
How can stockholders attend the ANI Pharmaceuticals virtual meeting?
What is the eligibility criteria for voting at the ANI Pharmaceuticals meeting?
Is there a replay available for the ANI Pharmaceuticals annual meeting?